Catalyst
Slingshot members are tracking this event:
Supernus (SUPN) Announces Early Release of Top-Line Phase 2b Data Evaluating ADHD drug SPN-812
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SUPN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 11, 2016
Occurred Source:
http://ir.supernus.com/releasedetail.cfm?ReleaseID=992959
Related Projects
- What Can We Expect from the Phase 2b Data of Supernus' ADHD drug SPN-812? SUPN Execute By: Nov 18, 2016
Related Keywords
Top-line Results, Phase 2b, Adhd, Spn-812
